The Lab Whose Junk Science Is Fueling a Frenzy of Litigation
Legitimate consumer protection demands sound science and impartial analysis — not distorted data designed to manufacture lawsuits.
This op-ed was originally published by The Hill.
A private lab scrutinized for its dubious scientific methods and for peddling junk science to trial lawyers on the taxpayer’s dime is now fueling a new wave of lawsuits against American manufacturers.
The latest target is the $5 billion acne medication industry. This is just the most recent example of what has burgeoned into a lucrative racket that must be stopped.
Valisure, a Connecticut-based laboratory, has become a one-stop shop for plaintiffs’ lawyers seeking to manufacture mass tort claims. The lab’s pattern is clear: Conduct unrealistic product testing, make alarming claims about contamination, and invite a litigation frenzy targeting what are perceived as deep-pocketed companies.
For example, Valisure claims to have detected benzene, a carcinogen, in certain acne products. But the lab’s methods are highly suspect. It subjected products to temperatures up to 158 degrees Fahrenheit, far exceeding the temperatures at which such topical acne products are intended to be stored or used. Not surprisingly, plaintiffs’ lawyers quickly pounced, filing more than 20 lawsuits against Walgreens, Kenvue, and others.
This isn’t Valisure’s first rodeo. The lab was behind the now-debunked Zantac litigation, which U.S. District Judge Robin Rosenberg eviscerated in late 2022. Rosenberg found that Valisure had used “unreliable methodologies” such as heating Zantac to over 200 degrees Fahrenheit, twice the temperature of the average healthy person. The judge blasted the lab’s “lack of documentation,” “lack of substantiation for analytical leaps,” and “lack of statistically significant data.”
Despite its track record of concocting junk science, Valisure somehow secured a lucrative contract last year from the U.S. Department of Defense to test medications for our troops. This is a disappointing misuse of taxpayer dollars, as the company is in no way deserving of such important responsibility in support of our service members and their families.
Valisure’s close ties to the plaintiffs’ bar raise even more concerns about serious conflicts of interest. Reports last year found that Valisure offered to conceal testing information in litigation against Unilever — for a price. It appears Valisure’s real business model is legal shakedowns, not science.
The lab, however, seems to have found some help from friends in high places. Rep. Rosa DeLauro (D-Conn.), whose district includes Valisure, played an integral role both in its securing the defense contract and in enabling this shakedown. Instead of probing Valisure’s credibility problems, DeLauro is pressuring the FDA to “hold accountable” companies that Valisure accuses, parroting the lab’s claims. Valisure itself states that it develops its own standards that “go beyond the current…benchmarks.”
As more lawsuits arise basing their claims on Valisure’s questionable testing practices, our courts and regulators must rigorously scrutinize this lab’s methods and potential conflicts of interest. Unchecked junk science erodes public trust, overwhelms the judicial system with meritless cases, and jeopardizes companies that produce essential everyday goods.
Rather than surrender to profit-driven litigation funded by plaintiffs’ lawyers, we must uphold rigorous scientific standards. The newly amended Federal Rule of Evidence 702 empowers and instructs judges to critically examine an expert’s methodology before allowing testimony — a crucial safeguard against the type of questionable, litigation-driven science promoted by Valisure.
Legitimate consumer protection demands sound science and impartial analysis — not distorted data designed to manufacture lawsuits. Safeguarding scientific integrity protects not just businesses targeted by this scheme, but the entire civil justice system’s credibility.
The American people deserve better than junk science proliferating frivolous litigation. It’s time to reject manipulated testing that enriches the few at the expense of the many. Our regulatory bodies, courts, and elected leaders must demand and uphold a fidelity to facts over avarice. Only then can we restore accountability to a system compromised by profit motives masquerading as consumer advocacy.
Tiger Joyce is president of the American Tort Reform Association.
Keep In Touch
Latest News
View all news
ATRA Commends Pennsylvania Lawmakers for Addressing Lawsuit Abuse
Pennsylvania lawmakers introduced liability reform bills to tackle lawsuit abuse. Proposed changes aim to enhance job creation and economic stability by limiting excessive litigation costs.
Hidden Influence: How Third-Party Litigation Financing Fuels Lawsuit Abuse
It’s time to pull back the curtain on third-party litigation financing and restore balance to our courts.
Lawsuit Abuse Awareness Week — Protecting Arizona’s Small Businesses
Lawsuit Abuse Awareness Week prompts reflection on Arizona’s civil justice system, highlighting excessive tort costs harming small businesses, job loss, and economic growth.
ATRA Kicks Off Lawsuit Abuse Awareness Week, Highlights Economic Burdens
This week is aimed at educating both the public and our government leaders about how excessive litigation drains resources from businesses, stifles innovation, and ultimately hurts consumers and job creation.
Shining a Light on Lawsuit Abuse: Kicking Off Lawsuit Abuse Awareness Week 2024
By fostering understanding and promoting smart reforms, we can help create a more balanced civil justice system that serves all citizens.
The Louisiana Supreme Court’s Alarming U-turn
The Pelican State deserves a judicial system that stands firmly on principles — not one swayed by the most recent political winds.